Pernas, Sonia http://orcid.org/0000-0002-1485-5080
Tolaney, Sara M. http://orcid.org/0000-0002-5940-8671
Article History
Received: 18 March 2021
Accepted: 17 March 2022
First Online: 9 April 2022
Declarations
:
: SP reports advisor/consultant role for AstraZeneca, Daiichi-Sankyo, Polyphor, Novartis, Eisai, Pierre-Fabre, SeattleGenetics, and Roche. SMT reports institutional research funding from AstraZeneca, Lilly, Merck, Nektar, Novartis, Pfizer, Genentech/Roche, Immunomedics, Exelixis, Bristol-Myers Squibb, Eisai, Nanostring, Cyclacel, Odonate, Seattle Genetics; and advisor/consultant role for AstraZeneca, Lilly, Merck, Nektar, Novartis, Pfizer, Genentech/Roche, Gilead, Immunomedics, Bristol-Myers Squibb, Eisai, Nanostring, Puma, Sanofi, Celldex, Paxman, Odonate, Seattle Genetics, Silverback Therapeutics, G1 Therapeutics, AbbVie, Anthenex, OncoPep, Outcomes4Me, Kyowa Kirin Pharmaceuticals, Daiichi-Sankyo, Samsung Bioepsis Inc.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.